Genetic modification of vascular endothelial function as therapeutic strategy in heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 2 58-2, 2005, Pages

  Lam, Chen Fuh ^a   Katusic, Zvonimir S ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; COPPER ZINC SUPEROXIDE DISMUTASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HYDRALAZINE; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SPIRONOLACTONE; STATINE DERIVATIVE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ARTERY RESISTANCE; BLOOD VESSEL WALL; DNA MODIFICATION; EDITORIAL; EXERCISE TOLERANCE; GENE TRANSFER; HEART FAILURE; HEART PROTECTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMIC VASCULAR RESISTANCE; TISSUE PERFUSION; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; CARDIAC OUTPUT, LOW; ENDOTHELIUM, VASCULAR; GENE THERAPY; HUMANS; SUPEROXIDE DISMUTASE;

EID: 23744434599     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00374.2005     Document Type: Editorial

References (12)

1. Bauersachs J, Bouloumie A, Fraccarollo D, Hu K, Busse R, and Ertl G. Endothelial dysfunction in chronic mayocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 100: 292-298, 1999.
2. Bauersachs J, Heck M, Fraccarollo D, Hildemann SK, Ertl G, Wehling M, and Christ M. Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. J Am Coll Cardiol 39: 351-358, 2002.
3. Ellis GR, Anderson RA, Lang D, Blackman DJ, Morris RHK, Morris-Thurgood J, McDowell IFW, Jackson SK, Lewis MJ, and Frenneaux MP. Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy. J Am Coll Cardiol 36: 1474-1482, 2000.
4. Faraci FM and Didion SP. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24: 1367-1373, 2004.
5. Hornig B, Arakawa N, Kohler C, and Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 97: 363-368, 1998.
6. Iida S, Chu Y, Francis J, Weiss RM, Gunnett CA, Faraci FM, and Heistad DD. Gene transfer of extracellular superoxide dismutase improves endothelial function in rats with heart failure. Am J Physiol Heart Circ Physiol 289: H000-H000, 2005.
7. Li JM and Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287: R1014-R1030, 2004.
8. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, and Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarization factor in mice. J Clin Invest 106: 1521-1530, 2000.
9. Munzel T and Harrison DG. Increased superoxide in heart failure: a biochemical baroreflex gone awry. Circulation 100: 216-218, 1999.
10. Schafer A, Fraccarollo D, Tas P, Schmidt I, Ertl G, and Bauersachs J. Endothelial dysfunction in congestive heart failure: ACE inhibition vs angiotensin II antagonism. Eur J Heart Fail 6: 151-159, 2004.
11. Taniyama Y and Griendling KK. Reactive oxygen species in the vasculature. Hypertension 42: 1075-1081, 2003.
12. Widder J, Behr T, Fraccarollo D, Hu K, Galuppo P, Tas P, Angermann CE, Ertl G, and Bauersachs J. Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent. Cardiovasc Res 63: 161-167, 2004.